Paysign, Inc. (NASDAQ:PAYS ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jeffery B. Baker - CFO & Treasurer Mark R.
Paysign has achieved strong double-digit revenue growth year-over-year and expanded its market share significantly. The company now controls about 50% of the plasma donation center market after adding 132 new centers. Paysign maintains a healthy balance sheet and expects to improve its bottom-line financials.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.